Investor's Business Daily on MSN
Moderna pops as Vinay Prasad, the FDA's controversial vaccine head, will depart in April
Moderna stock jumped late Friday on reports the FDA's top vaccine official, Vinay Prasad, will step down amid mounting ...
Boomi, the data activation company, today announced it has been recognised as a Leader and positioned highest for Ability to ...
The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson ...
RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
The approval represents a win in what’s been a difficult regulatory environment of late for vaccine makers, and could boost ...
Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance ...
The ECDC, the infectious diseases watchdog, has asked for scientists to join its new panel on RSV as Europe begins to vaccinate its most vulnerable adults.
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results